139 related articles for article (PubMed ID: 10593436)
1. The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion.
Larsson J; Hillarp A
Thromb Res; 1999 Nov; 96(4):323-7. PubMed ID: 10593436
[TBL] [Abstract][Full Text] [Related]
2. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
4. PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.
Kastrati A; Koch W; Gawaz M; Mehilli J; Böttiger C; Schömig K; von Beckerath N; Schömig A
J Am Coll Cardiol; 2000 Jul; 36(1):84-9. PubMed ID: 10898417
[TBL] [Abstract][Full Text] [Related]
5. Thrombophilic polymorphisms in pre-eclampsia: altered frequency of the functional 98C>T polymorphism of glycoprotein IIIa.
O'Shaughnessy KM; Fu B; Downing S; Morris NH
J Med Genet; 2001 Nov; 38(11):775-7. PubMed ID: 11732486
[No Abstract] [Full Text] [Related]
6. PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease.
Atzeni F; Boiardi L; Nicoli D; Farnetti E; Casali B; Sarzi-Puttini P; Pipitone N; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Filippini D; Paolazzi G; Salvarani C
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S38-43. PubMed ID: 21813062
[TBL] [Abstract][Full Text] [Related]
7. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
[TBL] [Abstract][Full Text] [Related]
8. Role of five platelet membrane glycoprotein polymorphisms in branch retinal vein occlusion.
Salomon O; Moisseiev J; Vilganski T; Dardik R; Kurtz S; Shpringer E; Steinberg DM; Rosenberg N
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):485-8. PubMed ID: 16905953
[TBL] [Abstract][Full Text] [Related]
9. PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.
Pourgheysari B; Boroujeni HR; Hasheminia AM; Drees F
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):471-6. PubMed ID: 23358226
[TBL] [Abstract][Full Text] [Related]
10. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester.
Pihusch R; Buchholz T; Lohse P; Rübsamen H; Rogenhofer N; Hasbargen U; Hiller E; Thaler CJ
Am J Reprod Immunol; 2001 Aug; 46(2):124-31. PubMed ID: 11506076
[TBL] [Abstract][Full Text] [Related]
11. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
[TBL] [Abstract][Full Text] [Related]
12. The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis.
Mikkelsson J; Perola M; Penttilä A; Goldschmidt-Clermont PJ; Karhunen PJ
Atherosclerosis; 2001 Feb; 154(3):721-7. PubMed ID: 11257275
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype.
Incorvaia C; Lamberti G; Parmeggiani F; Ferraresi P; Calzolari E; Bernardi F; Sebastiani A
Am J Ophthalmol; 1999 Aug; 128(2):247-8. PubMed ID: 10458191
[TBL] [Abstract][Full Text] [Related]
14. The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study.
Incorvaia C; Parmeggiani F; Costagliola C; Lamberti G; Ferraresi P; Bernardi F; Sebastiani A
Graefes Arch Clin Exp Ophthalmol; 2001 Apr; 239(4):251-6. PubMed ID: 11450488
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion.
Kalayci D; Gürgey A; Güven D; Parlak H; Hasiripi H
Acta Ophthalmol Scand; 1999 Dec; 77(6):622-4. PubMed ID: 10634550
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion.
Boyd S; Owens D; Gin T; Bunce K; Sherafat H; Perry D; Hykin PG
Br J Ophthalmol; 2001 Nov; 85(11):1313-5. PubMed ID: 11673296
[TBL] [Abstract][Full Text] [Related]
17. Prothrombotic gene mutations and Crohn's disease; is there any association?
Over-Hamzaoglu H; Abaci N; Türe F; Alkim C; Tezel A; Avsar E; Tözün N
Hepatogastroenterology; 2005; 52(65):1467-9. PubMed ID: 16201098
[TBL] [Abstract][Full Text] [Related]
18. Retinal vein occlusion and factor V Leiden and prothrombin 20210 G:A mutations.
Aras S; Yilmaz G; Alpas I; Baltaci V; Tayanç E; Aydin P
Eur J Ophthalmol; 2001; 11(4):351-5. PubMed ID: 11820306
[TBL] [Abstract][Full Text] [Related]
19. Role of thrombophilic gene polymorphisms in branch retinal vein occlusion.
Weger M; Renner W; Steinbrugger I; Cichocki L; Temmel W; Stanger O; El-Shabrawi Y; Lechner H; Schmut O; Haas A
Ophthalmology; 2005 Nov; 112(11):1910-5. PubMed ID: 16157382
[TBL] [Abstract][Full Text] [Related]
20. Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease.
Addad F; Elalamy I; Chakroun T; Abderrazek F; Dridi Z; Hamdi S; Hassine M; Ben-Farhat M; Gerotziafas G; Hatmi M; Gamra H
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):674-8. PubMed ID: 20739877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
